Recopharma Project

Leading organisations:
Universidad Autonoma de Barcelona, Lunds Universitet, University of Pau and Pays de l'Adour, Universidad de Udine, AERIS Tecnologías Ambientales, S.L., Spain, Europe For Business, Universidad de la Habana, and CIDEM

Timeframe:
2018 - 2022

Geographic Area:
Other

Objectives:

The RECOPHARMA Project was born with the purpose of developing an effective treatment to recover the CDs through the sequential integration of the potential offered by technologies such as Molecularly Imprinted Polymers (MIPs), Reagentless Thermosorption (RTS), Nanocomposites Functional Materials (NFMs) and Advanced Oxidation Processes (AOP).

The RECOPHARMA Project, formed by 8 partners (see partners section), is a Research and Innovation Staff Exchange action, fostering intersectorial mobility between Europe and Cuba.


Target audience:
Environmental experts, Pharmaceutical manufacturers, Scientists, and Water/waste service providers

Area of interest:
Occurrence of pharmaceuticals in the environment, Pharmaceutical waste & waste management, Risks to ecosystems, Risks to human health, Wastewater, and Water treatment technologies

Activities:

Communication material:

Contact person:
Prof. Manuel Valiente (Universitat Autònoma de Barcelona)
Return to search form.

HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.